Stem cell therapies and Parkinson’s – Michael J Fox Foundation webinar

News

Author: Joe McAweaneyPublished: 15 August 2019

Prep: Cook: Serves:

Tune in to the latest webinar in The Michael J Fox Foundation’s Third Thursdays series for an expert discussion on stem cell therapies and its potential treatments for Parkinson’s

The next episode of The Michael J Fox Foundation’s Third Thursdays webinar series will focus on stem cell therapies for Parkinson’s.

In the free hour-long webinar, a panel of Parkinson’s experts will discuss the status of stem cell therapies – and how they could be used to treat Parkinson’s. Panellists will also answer a range of questions on Parkinson’s from listeners.

There has been significant research into Parkinson’s and stem cells therapies, with studies suggesting that genetically edited cells may be able to counter the effects of the condition.

Last year, scientists from Kyoto University, Japan, carried out a world first trial – transplanting reprogrammed stem cells into people with Parkinson’s.

And in January, a team from the University of Edinburgh, UK, created Parkinson’s resistant stem cells. As part of the study, published in the ‘European Journal of Neuroscience’, the team used gene editing techniques to remove the alpha-synuclein protein from stem cells – preventing them from developing the condition.

To listen to this webinar, listeners must register here up to 15 minutes before it’s start time at 12:00 EST. If you cannot make the live broadcast, you can visit the archive to listen to a recording.

Cramping more than your style

Last Month

Next Month

Go Back

Share this story

Comments

Interviews

“I never expected to create a project like this with my son”

The mother-son duo making films about Parkinson’s disease

World Parkinson Congress: all about the sushi

We talk to Canadian WPC blogger Benjamin Stecher

World Parkinson Congress 2019 Bloggers: Mariëtte Robijn

#WPC2019: We talk to Dutch blogger Mariëtte Robijn

Could a sea sponge support the search for Parkinson’s disease treatments?

How could a molecule in a sea sponge help treat Parkinson’s and similar conditions? Researchers at the University of California, Los Angeles (UCLA), in the US, recently explored this question. Their findings were published in the journal ‘Science’. The team examined a molecule known as lissodendoric acid A, which appears to counteract other molecules that damage DNA, proteins and whole cells – and was recently discovered in a sea sponge. The research team used an oft-neglected compound called a cyclic allene to control a step in the chain of chemical reactions, which enabled them to create a version of the molecule in a lab. Scientists believe that the ability to synthetically produce lissodendoric acid A will help them assess whether it can inform future therapies for conditions like Parkinson’s. UCLA’s Professor Neil Garg, the corresponding author of the study, said: “We hope others will also be able to use cyclic…

Study finds just six minutes of daily exercise might delay onset of Parkinson’s disease

Regular exercise is a common therapeutic strategy for people with Parkinson’s. Now, a study from New Zealand has suggested that daily physical activity might even delay the onset of this condition. Published in ‘The Physiological Society’, the study focused on a protein called brain-derived neurotrophic factor (BDNF) – which has previously been shown to boost cognitive performance. The researchers assessed the impact of fasting and physical activity on BDNF production in 12 people aged 18 to 56. The tests involved fasting and completing exercises of varying intensity, such as cycling for six minutes, as well as combinations of both fasting and physical activity. The results showed that brief, intense exercise was the best option for increasing the production of BDNF – with the protein increasing by a factor of four to five times compared to light exercise or fasting. Because BDNF can protect the brain from cognitive decline, the findings could…

Machine learning may help predict risk of freezing of gait in Parkinson’s disease

Difficulty taking steps forward, often referred to as the freezing of gait (FOG), is a common symptom experienced by people with Parkinson’s and one that can be difficult to predict. China-based researchers suggest that machine learning – artificial intelligence (AI) that uses algorithms to analyse data – could help predict the risk of freezing of gait developing in the early stages of the condition. Their study, published in ‘npj Parkinson’s Disease’, gave laboratory and clinical data to a machine learning model brain. This information was collected from 158 adults with untreated early-stage Parkinson’s and 73 healthy adults over a five-year period. They found that the risk of FOG could be predicted with an accuracy rate of up to 78%. The study authors suggested that machine learning methods “have the potential to help predict future FOG in patients with early Parkinson’s at an individual level”.

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Name
This field is for validation purposes and should be left unchanged.

Stem cell therapies and Parkinson’s – Michael J Fox Foundation webinar

News

Author: Joe McAweaneyPublished: 15 August 2019

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Interviews

“I never expected to create a project like this with my son”

Interviews

World Parkinson Congress: all about the sushi

Perspectives

World Parkinson Congress 2019 Bloggers: Mariëtte Robijn

Could a sea sponge support the search for Parkinson’s disease treatments?

Study finds just six minutes of daily exercise might delay onset of Parkinson’s disease

Machine learning may help predict risk of freezing of gait in Parkinson’s disease

{title}

Subscribe

Stem cell therapies and Parkinson’s – Michael J Fox Foundation webinar

News

Author: Joe McAweaneyPublished: 15 August 2019

Last Month

Next Month

Share this story

Comments

Related articles

Interviews

“I never expected to create a project like this with my son”

Interviews

World Parkinson Congress: all about the sushi

Perspectives

World Parkinson Congress 2019 Bloggers: Mariëtte Robijn

Could a sea sponge support the search for Parkinson’s disease treatments?

Study finds just six minutes of daily exercise might delay onset of Parkinson’s disease

Machine learning may help predict risk of freezing of gait in Parkinson’s disease

{title}

Subscribe

Sign in